GAP T cells / Baylor College of Medicine - LARVOL DELTA

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) (clinicaltrials.gov) - P1 | N=10 | Active, not recruiting | Sponsor: Baylor College of Medicine | Recruiting ➔ Active, not recruiting | N=18 ➔ 10 | Trial primary completion date: Jan 2022 ➔ Sep 2021

Enrollment change • Enrollment closed • Trial primary completion date • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Pediatrics • Solid Tumor • GPC3